Non-psychoactive Cannabinoid May Enable Drug Addiction Recovery

An animal study finds that cannabidiol (CBD), a non-psychoactive chemical found in marijuana, may help reduce the risk of drug and alcohol relapse. The research, conducted by the Scripps Research Institute, was funded by the National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, both part of the National Institutes of Health.

Read the article >

Related posts

Oral Cannabidiol Prevents Neurological Dysfunctions in a Mouse Model of Mild Traumatic Brain Injury

/ 0
Our data....suggests the CBD as a pharmacological tool to improve neurological dysfunctions caused by traumatic brain injury (TBI). Read full article >

CBD Versus Nicotine

/ 0
The role of the endocannabinoid system in nicotine addiction is being increasingly acknowledged. Researchers conducted a pilot, randomised double blind placebo controlled study set out to assess...

CBD may help the heart, inflammation and more…

/ 0

In this study, we have investigated the effects of cannabidiol (CBD) on myocardial dysfunction, inflammation, oxidative/nitrosative stress, cell death and interrelated signaling pathways, using a…

CBD May Help Fibromyalgia and Psychological Conditions

The “classic” endocannabinoid (eCB) system includes the cannabinoid receptors CB1 and CB2, the eCB ligands anandamide (AEA) and 2-arachidonoylglycerol (2-AG), and their metabolic enzymes. An emerging...

Comments are closed

© 2023 Hemp Apotheke

© Created by  8theme - Power Elite ThemeForest Author.